Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today it has filed a registration... read more
Enterome SA announced on 3/20/19 that is has entered into a research and development collaboration with Dana-Farber Cancer Institute (Boston, MA) to evaluate and develop gut microbiome-derived... read more
Flagship Pioneering announced on 3/20/19 that it has secured $824 million in a new capital pool to support the growth of human health and sustainability companies originated by its Flagship Labs... read more
Download the full report here.
JD Supra just released its Life Sciences Report for Winter and... read more